Dr. Nicole Paulk
Showing 1–1 of 1 transcripts.
- All-In Podcast31 min
All-In Summit: Gene therapy and a new era of medicine with Dr. Nicole Paulk
Dr. Nicole Paulk, Chamath, Calacanis, Friedberg
Dr. Nicole Paul's Siren Biotechnology is transitioning from stealth to clinical trials with a universal AAV platform designed to treat cancer by engineering viral logic circuits that reactivate immune surveillance against invisible tumors. Preclinical data demonstrates functional cures in human brain cancer models, positioning the company to launch its first trial in 2025 despite facing significant industry headwinds including manufacturing bottlenecks and restrictive FDA regulations. While the immediate focus remains on oncology, the technology aims to eventually enable human augmentation and longevity applications, contingent upon future regulatory shifts regarding non-disease therapeutic targets.